{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:30:50Z","timestamp":1788546650160,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.7759\/cureus.57260","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T14:25:58Z","timestamp":1711808758000},"source":"Crossref","is-referenced-by-count":10,"title":["The Rise of Remimazolam: A Review of Pharmacology, Clinical Efficacy, and Safety Profiles"],"prefix":"10.7759","author":[{"given":"Saiesh","family":"Dessai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjot","family":"Ninave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Bele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick GJ","year":"2021","unstructured":"Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent. Front Pharmacol. 2021, 12:690875. 10.3389\/fphar.2021.690875","journal-title":"Front Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New benzodiazepines for sedation","volume":"32","author":"Cornett EM","year":"2018","unstructured":"Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD. New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol. 2018, 32:149-64. 10.1016\/j.bpa.2018.06.007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000792","article-title":"Procedural sedation in ambulatory anaesthesia: what's new?","volume":"32","author":"Raeder J","year":"2019","unstructured":"Raeder J. Procedural sedation in ambulatory anaesthesia: what's new?. Curr Opin Anaesthesiol. 2019, 32:743-8. 10.1097\/ACO.0000000000000792","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(97)01118-8","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel E","year":"1997","unstructured":"Sigel E, Buhr A. The benzodiazepine binding site of GABAA receptors. Trends Pharmacol Sci. 1997, 18:425-9. 10.1016\/S0165-6147(97)01118-8","journal-title":"Trends Pharmacol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01544-8","article-title":"Remimazolam: a review in procedural sedation","volume":"81","author":"Lee A","year":"2021","unstructured":"Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021, 81:1193-201. 10.1007\/s40265-021-01544-8","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823acb95","article-title":"Remimazolam: new beginnings or just a me-too?","volume":"115","author":"Sneyd JR","year":"2012","unstructured":"Sneyd JR. Remimazolam: new beginnings or just a me-too?. Anesth Analg. 2012, 115:217-9. 10.1213\/ANE.0b013e31823acb95","journal-title":"Anesth Analg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2014.3911R","article-title":"Recent advances in the design and development of soft drugs","volume":"69","author":"Buchwald P","year":"2014","unstructured":"Buchwald P, Bodor N. Recent advances in the design and development of soft drugs. Pharm. 2014, 69:403-13. 10.1691\/ph.2014.3911R","journal-title":"Pharm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002717","article-title":"Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology","volume":"63","author":"Saari TI","year":"2011","unstructured":"Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev. 2011, 63:243-67. 10.1124\/pr.110.002717","journal-title":"Pharmacol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4097\/kja.22078","article-title":"How general anesthetics work: from the perspective of reorganized connections within the brain","volume":"75","author":"Shin TJ","year":"2022","unstructured":"Shin TJ, Kim PJ, Choi B. How general anesthetics work: from the perspective of reorganized connections within the brain. Korean J Anesthesiol. 2022, 75:124-38. 10.4097\/kja.22078","journal-title":"Korean J Anesthesiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4097\/kja.22297","article-title":"Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent","volume":"75","author":"Kim SH","year":"2022","unstructured":"Kim SH, Fechner J. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent. Korean J Anesthesiol. 2022, 75:307-15. 10.4097\/kja.22297","journal-title":"Korean J Anesthesiol"},{"key":"ref11","article-title":"CNS 7056X, an ultra-short acting benzodiazepine: in vitro metabolism","volume":"105","author":"Tilbrook GS","year":"2006","unstructured":"Tilbrook GS, Kilpatrick GJ. CNS 7056X, an ultra-short acting benzodiazepine: in vitro metabolism. Anesthesiology. 2006, 105:1611.","journal-title":"Anesthesiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S186759","article-title":"Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system","volume":"13","author":"Freyer N","year":"2019","unstructured":"Freyer N, Kn\u00f6spel F, Damm G, et al.. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019, 13:1033-47. 10.2147\/DDDT.S186759","journal-title":"Drug Des Devel Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick GJ","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, et al.. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007, 107:60-6. 10.1097\/01.anes.0000267503.85085.c0","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure SC","year":"2013","unstructured":"Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB. The role of human carboxylesterases in drug metabolism: have we overlooked their importance?. Pharmacotherapy. 2013, 33:210-22. 10.1002\/phar.1194","journal-title":"Pharmacotherapy"},{"key":"ref15","article-title":"Remimazolam dose finding studies for anesthetic\/sedative in the indication general anesthesia in Japanese volunteers\/patients","volume":"3011","author":"Doi M","year":"2015","unstructured":"Doi M, Morita K, Shiraishi Y, Katoh T, Kurita T, Igarashi H, Sato S. Remimazolam dose finding studies for anesthetic\/sedative in the indication general anesthesia in Japanese volunteers\/patients. Anesthesiol A. 2015, 3011:..","journal-title":"Anesthesiol A"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi M","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020, 34:543-53. 10.1007\/s00540-020-02788-6","journal-title":"J Anesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2199\/jjsca.34.860","article-title":"Remimazolam (Article in Japanese)","volume":"34","author":"Doi M","year":"2014","unstructured":"Doi M. Remimazolam (Article in Japanese). J Jpn Soc Clin Anesth. 2014, 34:860-6. 10.2199\/jjsca.34.860","journal-title":"J Jpn Soc Clin Anesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182a705ae","article-title":"A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy","volume":"117","author":"Worthington MT","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, Mitchell MC. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013, 117:1093-100. 10.1213\/ANE.0b013e3182a705ae","journal-title":"Anesth Analg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01561-z","article-title":"Sedation practices for routine gastrointestinal endoscopy: a systematic review of recommendations","volume":"21","author":"Dossa F","year":"2021","unstructured":"Dossa F, Megetto O, Yakubu M, Zhang DD, Baxter NN. Sedation practices for routine gastrointestinal endoscopy: a systematic review of recommendations. BMC Gastroenterol. 2021, 21:22. 10.1186\/s12876-020-01561-z","journal-title":"BMC Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy","volume":"83","author":"Pambianco DJ","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, Wilhelm-Ogunbiyi K. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016, 83:984-92. 10.1016\/j.gie.2015.08.062","journal-title":"Gastrointest Endosc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0b013e32833b9c9f","article-title":"Standardizing care and monitoring for anesthesia or procedural sedation delivered outside the operating room","volume":"23","author":"Eichhorn V","year":"2010","unstructured":"Eichhorn V, Henzler D, Murphy MF. Standardizing care and monitoring for anesthesia or procedural sedation delivered outside the operating room. Curr Opin Anaesthesiol. 2010, 23:494-9. 10.1097\/ACO.0b013e32833b9c9f","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002043","article-title":"Practice guidelines for moderate procedural sedation and analgesia 2018: a report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology","volume":"128","author":"American Society of Anesthesiologists","year":"2018","unstructured":"American Society of Anesthesiologists. Practice guidelines for moderate procedural sedation and analgesia 2018: a report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology. 2018, 128:437-79. 10.1097\/ALN.0000000000002043","journal-title":"Anesthesiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler J","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020, 132:636-51. 10.1097\/ALN.0000000000003103","journal-title":"Anesthesiology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902065","article-title":"The efficacy and safety of remimazolam tosilate versus dexmedetomidine in outpatients undergoing flexible bronchoscopy: a prospective, randomized, blind, non-inferiority trial","volume":"13","author":"Chen X","year":"2022","unstructured":"Chen X, Xin D, Xu G, Zhao J, Lv Q. The efficacy and safety of remimazolam tosilate versus dexmedetomidine in outpatients undergoing flexible bronchoscopy: a prospective, randomized, blind, non-inferiority trial. Front Pharmacol. 2022, 13:902065. 10.3389\/fphar.2022.902065","journal-title":"Front Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/BF03002226","article-title":"Diazepam as an intravenous induction agent for general anaesthesia","volume":"13","author":"McClish A","year":"1966","unstructured":"McClish A. Diazepam as an intravenous induction agent for general anaesthesia. Can Anaesth Soc J. 1966, 13:562-75. 10.1007\/BF03002226","journal-title":"Can Anaesth Soc J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/BF03004881","article-title":"Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam","volume":"25","author":"Reves JG","year":"1978","unstructured":"Reves JG, Corssen G, Holcomb C. Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam. Can Anaesth Soc J. 1978, 25:211-4. 10.1007\/BF03004881","journal-title":"Can Anaesth Soc J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik LJ","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012, 115:274-83. 10.1213\/ANE.0b013e31823f0c28","journal-title":"Anesth Analg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02776-w","article-title":"Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial","volume":"34","author":"Doi M","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020, 34:491-501. 10.1007\/s00540-020-02776-w","journal-title":"J Anesth"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S428278","article-title":"Comparative study about different doses of remimazolam in short laparoscopic surgery: a randomized controlled double-blind trial","volume":"19","author":"Luo L","year":"2023","unstructured":"Luo L, Jiang J, Zhang M, Guo Z, Zhang X, Wang F, Yang F. Comparative study about different doses of remimazolam in short laparoscopic surgery: a randomized controlled double-blind trial. Ther Clin Risk Manag. 2023, 19:829-37. 10.2147\/TCRM.S428278","journal-title":"Ther Clin Risk Manag"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165402","article-title":"Remimazolam's effects on postoperative nausea and vomiting are similar to those of propofol after laparoscopic gynecological surgery: a randomized controlled trial","volume":"12","author":"Matsumoto A","year":"2023","unstructured":"Matsumoto A, Satomi S, Kakuta N, et al.. Remimazolam's effects on postoperative nausea and vomiting are similar to those of propofol after laparoscopic gynecological surgery: a randomized controlled trial. J Clin Med. 2023, 12:5402. 10.3390\/jcm12165402","journal-title":"J Clin Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-023-00661-5","article-title":"Effect of remimazolam versus sevoflurane on intraoperative hemodynamics in noncardiac surgery: a retrospective observational study using propensity score matching","volume":"9","author":"Katsuragawa T","year":"2023","unstructured":"Katsuragawa T, Mimuro S, Sato T, Aoki Y, Doi M, Katoh T, Nakajima Y. Effect of remimazolam versus sevoflurane on intraoperative hemodynamics in noncardiac surgery: a retrospective observational study using propensity score matching. JA Clin Rep. 2023, 9:70. 10.1186\/s40981-023-00661-5","journal-title":"JA Clin Rep"},{"key":"ref32","article-title":"Efficacy and safety of remimazolam tosilate combined with propofol in digestive endoscopy: a randomised trial","volume":"2023","author":"Cui L","year":"2023","unstructured":"Cui L, Shu K, Zhang P, et al.. Efficacy and safety of remimazolam tosilate combined with propofol in digestive endoscopy: a randomised trial. J Clin Pharm Ther. 2023, 2023:9955312.","journal-title":"J Clin Pharm Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S384155","article-title":"Remimazolam: an updated review of a new sedative and anaesthetic","volume":"16","author":"Hu Q","year":"2022","unstructured":"Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022, 16:3957-74. 10.2147\/DDDT.S384155","journal-title":"Drug Des Devel Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.03.028","article-title":"Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review","volume":"127","author":"Sneyd JR","year":"2021","unstructured":"Sneyd JR, Gambus PL, Rigby-Jones AE. Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review. Br J Anaesth. 2021, 127:41-55. 10.1016\/j.bja.2021.03.028","journal-title":"Br J Anaesth"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000877","article-title":"Remimazolam for anaesthesia or sedation","volume":"33","author":"Sneyd JR","year":"2020","unstructured":"Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020, 33:506-11. 10.1097\/ACO.0000000000000877","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S375957","article-title":"Profile of remimazolam in anesthesiology: a narrative review of clinical research progress","volume":"16","author":"Wang M","year":"2022","unstructured":"Wang M, Zhao X, Yin P, Bao X, Tang H, Kang X. Profile of remimazolam in anesthesiology: a narrative review of clinical research progress. Drug Des Devel Ther. 2022, 16:3431-44. 10.2147\/DDDT.S375957","journal-title":"Drug Des Devel Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4870","article-title":"Remimazolam as a primary agent for brief invasive and noninvasive procedures: a case series","volume":"15","author":"Yeh J","year":"2023","unstructured":"Yeh J, McKee C, Chenault K, Tobias JD. Remimazolam as a primary agent for brief invasive and noninvasive procedures: a case series. J Clin Med Res. 2023, 15:174-80. 10.14740\/jocmr4870","journal-title":"J Clin Med Res"},{"key":"ref38","article-title":"Clinical pharmacology of flumazenil","volume":"2","author":"Amrein R","year":"1988","unstructured":"Amrein R, Hetzel W, Hartmann D, Lorscheid T. Clinical pharmacology of flumazenil. Eur J Anaesthesiol Suppl. 1988, 2:65-80.","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142060-00010","article-title":"Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist","volume":"42","author":"Brogden RN","year":"1991","unstructured":"Brogden RN, Goa KL. Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist. Drugs. 1991, 42:1061-89. 10.2165\/00003495-199142060-00010","journal-title":"Drugs"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-021-02915-x","article-title":"Re-sleeping after reversal of remimazolam by flumazenil","volume":"35","author":"Yamamoto T","year":"2021","unstructured":"Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021, 35:322. 10.1007\/s00540-021-02915-x","journal-title":"J Anesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/236779-the-rise-of-remimazolam-a-review-of-pharmacology-clinical-efficacy-and-safety-profiles","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T14:26:07Z","timestamp":1711808767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/236779-the-rise-of-remimazolam-a-review-of-pharmacology-clinical-efficacy-and-safety-profiles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.57260","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,30]]}}}